Surgical enucleation for renal cell carcinoma

Area of Science:

• Urology
• Nephrology
• Surgical Oncology

Background:

• Renal carcinoma presents unique challenges, especially in patients with bilateral disease or a solitary kidney.
• Nephron-sparing surgery is increasingly preferred for localized renal tumors to preserve kidney function.

Purpose of the Study:

• To review the outcomes of renal tumor enucleation in patients with compromised renal status.
• To evaluate the safety and efficacy of enucleation for renal carcinoma in selected cases.

Main Methods:

• Retrospective review of 33 patients undergoing renal tumor enucleation.
• Analysis of tumor grade, pathological stage, and postoperative follow-up data.
• Calculation of actuarial survival rates and local recurrence rates.

Main Results:

• All excised tumors were low grade and predominantly pathological stage I.
• Postoperative follow-up averaged 45 months (range 9-156 months).
• The 3-year actuarial survival rate was 90%, with only 6% local tumor recurrence.

Conclusions:

• Renal tumor enucleation is a safe and effective surgical option for selected patients with renal carcinoma.
• Enucleation provides excellent tumor control and preserves renal function in cases of bilateral or solitary kidney tumors.